Seyed Javad Rekabpour

3 ta ish

Salman Farsi University of Kazerun

1. Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers

   Majid Assadi, Seyed Javad Rekabpour, Esmail Jafari +9

   Maqola20213 iqtibos

   ABIABI:AkademIndex/2026.other.340322

2. Fibroblast Activation Protein Inhibitor Theranostics in Sarcoma

   Esmail Jafari, Malik Juweid, Narges Jokar +3

   MaqolaPeptidase Inhibition and AnalysisClinical Nuclear Medicine20260 iqtibos

   ABIABI:AkademIndex/2026.article.005082

3. Preliminary Evaluation of 225Ac/177Lu-DOTATATE PRRT in Progressive Meningiomas

   Reza Nemati, M I Juweid, Esmail Jafari +5

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.036566